GlucoTrack, Inc.
(NASDAQ : GCTK)

( )
GCTK PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.03%535.631.0%$648.52m
DHRDanaher Corp. 0.36%252.780.7%$635.19m
MDTMedtronic Plc 1.28%90.340.6%$612.83m
ABTAbbott Laboratories 1.91%109.010.8%$601.34m
ISRGIntuitive Surgical, Inc. 0.30%202.590.8%$423.22m
BSXBoston Scientific Corp. 0.77%37.791.0%$333.72m
ALGNAlign Technology, Inc. 0.10%242.156.4%$293.90m
BDXBecton, Dickinson & Co. 1.93%249.251.0%$275.67m
EWEdwards Lifesciences Corp. 1.33%95.990.4%$271.04m
SYKStryker Corp. 0.89%198.861.3%$258.39m
IDXXIDEXX Laboratories, Inc. 2.58%358.223.8%$231.23m
AAgilent Technologies, Inc. 0.63%117.801.7%$206.87m
BAXBaxter International, Inc. 0.82%65.791.8%$203.09m
DXCMDexCom, Inc. 1.00%75.451.9%$174.20m
SWAVShockwave Medical, Inc. -0.60%194.370.0%$168.16m

Company Profile

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Or Yehuda, Israel.